Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hagar.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Celon, Cel-Sci, Clene, Clover, Intra-Cellular, Kyverna, Mitsubishi Tanabe, Taysha Gene Therapies, TME.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Aerovate, Astrazeneca, Biomarin, Carsgen, Electra, Enlivex, Evaxion, Galapagos, Hutchmed, Innate, Janssen, Keros, Mirum, Mustang, Nurix, Roche, Salarius, Scilex, Sumitomo, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baropace, Cordis.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biosion, Gannex, Junshi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cantargia, Ocular Therapeutics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Delve Bio, Glucomodicum, Natera.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cara, Cardiol, Icell Gene, Nkgen Biotech, Pfizer.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Avidity, Biosion, City of Hope, Junshi, Nodthera, PDS, Ultragenyx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Annovis, Arcutis, Coya, Gannex, Processa, Sage, Tracon, Ultimovacs, Viridian.